Dana Chuderland

1.9k citations
30 papers · 1.4k indexed · h-index 21

Dana Chuderland

29 papers receiving 1.4k citations

Peers

Dana Chuderland
Comparison fields: 5 of 95
  • Reproductive Medicine 367
  • Cancer Research 177
  • Cell Biology 183
  • Molecular Biology 763
  • Immunology 194
Replace Leslie O. Goodwin with:
Leslie O. Goodwin United States
Fayçal Boussouar France
A.M. Zamah United States
Vadim Iourgenko United States
Nobuo Kamada Japan
Ingrid C. Gaemers Netherlands
Atish Mukherjee United States
Jeong Su Oh South Korea
Caroline J. Speed Australia
Margarita Kamenetsky United States
Dana Chuderland relative to Leslie O. Goodwin United States Leslie O. Goodwin's profile →
Citations per field
00.5×2.8×
Leslie O. Goodwin · 1×
Citations per year

Countries citing papers authored by Dana Chuderland

Since Specialization
Citations

This map shows the geographic impact of Dana Chuderland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Chuderland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Chuderland more than expected).

Fields of papers citing papers by Dana Chuderland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Chuderland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Chuderland. The network helps show where Dana Chuderland may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dana Chuderland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dana Chuderland Line = papers co-authored together Dana Chuderland links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20232
2 202222
3 20203
4 20207
5 201925
6 201623
7 201510
8 201531
9 2014107
10 201448
11 201422
12 201412
13 201336
14 201315
15 201234
16 20128
17 200858
18 200873
19 2008208
20 200480

About Dana Chuderland

Dana Chuderland is a scholar working on Reproductive Medicine, Cell Biology and Toxicology, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ovarian function and disorders (12 papers), Reproductive Biology and Fertility (8 papers), Endometriosis Research and Treatment (6 papers), Estrogen and related hormone effects (5 papers), Hypothalamic control of reproductive hormones (4 papers), Angiogenesis and VEGF in Cancer (4 papers), melanin and skin pigmentation (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Reproductive Medicine (367 citations), Cancer Research (177 citations) and Cell Biology (183 citations). Dana Chuderland has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Rony Seger, Alexander Konson, Ruth Shalgi, Hadas Grossman, Sarah Kraus, Zvi Naor, Mordechai Liscovitch, David Bonfil, Markus Meyer and Elke Burgermeister. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular Cell and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026